Among the 18 Treg-specific overlapping genes, ACP5, MAGEH1, TNFRSF9 and CCR8 were exclusively expressed in tumor-infiltrating Tregs and are potential immunotherapy targets for tumor-infiltrating Tregs. Here, TNFRSF9 is linked to neoplasm.